Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
2.975
-0.245 (-7.60%)
Aug 14, 2025, 1:52 PM - Market open
Immuneering Market Cap
Immuneering has a market cap or net worth of $108.06 million as of August 14, 2025. Its market cap has increased by 184.70% in one year.
Market Cap
108.06M
Enterprise Value
89.14M
1-Year Change
184.70%
Ranking
Category
Stock Price
$2.98
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $108.06M, a decrease of -70.46%. That is a compound annual growth rate of -26.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 115.87M | 69.63% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| Novartis AG | 234.72B |
| AstraZeneca | 232.33B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |